Compass is a clinical-stage biotechnology company focused on developing psychedelics-based drugs for neuropsychiatric disorders. The analyst equates COMP360 to Spravato 2.0. Johnson & Johnson’s ...

In 2024, a year in which single-family residential resale transactions were at a 29-year low, Compass outperformed. In Q4, the company reported a revenue increase of 26% year over year, reaching $1.4 ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Daniel Geiger Every time Daniel publishes a story, you’ll get an alert straight to your inbox!

Compass Inc. stock (NYSE: COMP) has been experiencing significant pressure, having declined over 15% within the last week, while the S&P 500 only fell by 0.6%. The catalyst for this decline: Compass’s ...

Compass Inc. (NYSE:COMP) shares fell more than 12% while Anywhere Real Estate Inc. (NYSE:HOUS) jumped over 52% on Monday after the companies announced a $10 billion all-stock merger, including debt.

Compass cements its dominance in U.S. real estate brokerage with an all-stock acquisition of Anywhere Real Estate. The Anywhere deal more than doubles Compass' adjusted EBITDA and revenue base, ...

Final arguments have been filed in the Compass-Zillow lawsuit over listing access. The court’s decision on the preliminary injunction is expected in the coming months. AI Summary Compass and Zillow ...

New perk: Easily find new routes and hidden gems, upcoming running events, and more near you. Your weekly Local Running Newsletter has everything you need to lace up! Subscribe today. Master the art ...

The real-estate brokerage Compass announced on June 14 that it was laying off 10% of its employees. CEO Robert Reffkin addressed the layoffs in an emailed memo to staff viewed by Insider. He said the ...